Vimarsana
Biggest News Aggregation in the World

Page 31 - Biochemistry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biochemistry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biochemistry Today - Breaking & Trending Today

Cell mechanics research is making chemotherapy friendlier - Vimarsana News

Cell mechanics research is making chemotherapy friendlier

Credit: Source: IFJ PAN Malignant tumour cells undergo mechanical deformation more easily than normal cells, allowing them to migrate throughout the body. The mechanical properties of prostate cancer cells treated with the most commonly used anti-cancer drugs have been investigated at the Institute of Nuclear Physics of the Polish Academy of Sciences in Cracow. According to the researchers, current drugs can be used more effectively and at lower doses. In cancer, a key factor contributing to the formation of metastasis is the ability of the neoplastic cells to undergo mechanical deformation. ...

University of Kentucky researchers discover fundamental roles of glucosamine in brain - Vimarsana News

University of Kentucky researchers discover fundamental roles of glucosamine in brain

Using novel imaging methods for studying brain metabolism, University of Kentucky researchers have identified the reservoir for a necessary sugar in the brain. Glycogen serves as a storage depot for the sugar glucose.

What is Biochemistry? - Vimarsana News

What is Biochemistry?

Biochemistry is the field of science that studies the chemical processes taking place within living organisms at the molecular level.

Novel approaches in treating neurodegenerative disorders - Vimarsana News

Novel approaches in treating neurodegenerative disorders

This book presents distinct advanced treatment alternatives for Neurodegenerative diseases that will be of significant interest for scientists and researchers working in this field.

Metabolic inhibitor IACS-6274 shows early antitumor effects in underserved patients - Vimarsana News

Metabolic inhibitor IACS-6274 shows early antitumor effects in underserved patients

Credit: MD Anderson Cancer Center HOUSTON -- The glutaminase (GLS1) inhibitor IACS-6274, discovered and developed by The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division, appears to be well-tolerated with successful target inhibition and early signs of anti-tumor activity in a biomarker-driven Phase I trial. Interim results of the study will be presented at the 2021 American Society for Clinical Oncology (ASCO) Annual Meeting on June 4. On the trial, 17 of 20 evaluable patients achieved a best response of stable disease, with a disease control rate of 60% at 12 ...